| COVID-19 among patients with multiple sclerosis: a systematic review M Barzegar, O Mirmosayyeb, M Gajarzadeh, A Afshari-Safavi, N Nehzat, ... Neurology: Neuroimmunology & Neuroinflammation 8 (4), e1001, 2021 | 95 | 2021 |
| COVID-19 infection in a patient with multiple sclerosis treated with fingolimod M Barzegar, O Mirmosayyeb, N Nehzat, R Sarrafi, F Khorvash, AH Maghzi, ... Neurology: Neuroimmunology & Neuroinflammation 7 (4), e753, 2020 | 83 | 2020 |
| Clinical characteristics and disability progression of early-and late-onset multiple sclerosis compared to adult-onset multiple sclerosis O Mirmosayyeb, S Brand, M Barzegar, A Afshari-Safavi, N Nehzat, ... Journal of clinical medicine 9 (5), 1326, 2020 | 83 | 2020 |
| Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study M Barzegar, S Vaheb, O Mirmosayyeb, A Afshari-Safavi, N Nehzat, ... Multiple sclerosis and related disorders 52, 102947, 2021 | 66 | 2021 |
| Early predictors of conversion to secondary progressive multiple sclerosis M Barzegar, S Najdaghi, A Afshari-Safavi, N Nehzat, O Mirmosayyeb, ... Multiple sclerosis and related disorders 54, 103115, 2021 | 42 | 2021 |
| The prevalence of migraine in multiple sclerosis (MS): A systematic review and meta-analysis O Mirmosayyeb, M Barzegar, N Nehzat, V Shaygannejad, MA Sahraian, ... Journal of Clinical Neuroscience 79, 33-38, 2020 | 36 | 2020 |
| Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic M Ghajarzadeh, O Mirmosayyeb, M Barzegar, N Nehzat, S Vaheb, ... Multiple Sclerosis and Related Disorders 43, 102222, 2020 | 36 | 2020 |
| Characteristics of COVID-19 disease in multiple sclerosis patients M Barzegar, O Mirmosayyeb, M Ghajarzadeh, N Nehzat, S Vaheb, ... Multiple Sclerosis and Related Disorders 45, 102276, 2020 | 33 | 2020 |
| Frequency of comorbidities in Neuromyelitis Optica spectrum disorder M Barzegar, O Mirmosayyeb, N Nehzat, S Vaheb, V Shaygannejad, ... Multiple Sclerosis and Related Disorders 48, 102685, 2021 | 20 | 2021 |
| Comparison of sleep complaints and quality of life between patients with neuromyelitis optica spectrum disorder (NMOSD) and healthy controls M Barzegar, DS Bahmani, N Nehzat, M Kiani, N Hashemi, O Mirmosayyeb, ... Multiple sclerosis and related disorders 32, 81-87, 2019 | 20 | 2019 |
| Fear of relapse, social support, and psychological well-being (depression, anxiety, and stress level) of patients with multiple sclerosis (MS) during the COVID-19 … V Shaygannejad, O Mirmosayyeb, N Nehzat, M Ghajarzadeh Neurological Sciences 42, 2615-2618, 2021 | 18 | 2021 |
| Prevalence of seizure/epilepsy in patients with multiple sclerosis: a systematic review and meta-analysis O Mirmosayyeb, V Shaygannejad, N Nehzat, A Mohammadi, ... International Journal of Preventive Medicine 12 (1), 14, 2021 | 18 | 2021 |
| Prevalence and risk factors of dysphagia in patients with multiple sclerosis M Barzegar, O Mirmosayeb, M Rezaei, G Bjørklund, N Nehzat, ... Dysphagia 37 (1), 21-27, 2022 | 14 | 2022 |
| COVID-19 infection in a patient with multiple sclerosis treated with fingolimod. Neurol Neuroimmunol Neuroinflamm 7 (4) M Barzegar, O Mirmosayyeb, N Nehzat, R Sarrafi, F Khorvash, AH Maghzi, ... | 9 | 2020 |
| The prevalence of sexual dysfunction and erectile dysfunction in men with multiple sclerosis: A systematic review and meta-analysis V Shaygannejad, O Mirmosayyeb, S Vaheb, N Nehzat, M Ghajarzadeh Neurología (English Edition), 2022 | 8 | 2022 |
| Association of helicobacter pylori with multiple sclerosis: Protective or risk factor? O Mirmosayyeb, M Barzegar, N Nehzat, S Najdaghi, B Ansari, ... Current Journal of Neurology 19 (2), 59, 2020 | 8 | 2020 |
| Efficacy and safety of rituximab in treating patients with neuromyelitis optica spectrum disorder (NMOSD): a systematic review and meta-analysis O Mirmosayyeb, V Shaygannejad, M Barzegar, N Nehzat, M Ghajarzadeh Autoimmunity reviews 20 (2), 102727, 2021 | 6 | 2021 |
| COVID-19 among patients with multiple sclerosis: a systematic review. Neurol Neuroimmunol Neuroinflamm 8: e1001 M Barzegar, O Mirmosayyeb, M Gajarzadeh | 6 | 2021 |
| Higher disease and pain severity and fatigue and lower balance skills are associated with higher prevalence of falling among individuals with the inflammatory disease of … M Barzegar, D Sadeghi Bahmani, O Mirmosayyeb, R Azarbayejani, ... Journal of clinical medicine 9 (11), 3604, 2020 | 6 | 2020 |
| assessment of coping strategies in patients with neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis M Barzegar, S Allahdadian, O Mirmosayyeb, R Azarbayejani, S Badihian, ... Psychology, Health & Medicine 27 (6), 1234-1244, 2022 | 3 | 2022 |
Omid Mirmosayyeb, MDDepartment of Neurology, Jacobs School of Medicine and Biomedical Sciences, University of BuffaloVerified email at buffalo.edu